Teach prescribers about dangers of long-acting pain meds: FDA

July 9, 2012 By Steven Reinberg, HealthDay Reporter
Teach prescribers about dangers of long-acting pain meds: FDA
Abuse, misuse, deaths from narcotic pain meds on the rise.

(HealthDay) -- As part of its efforts to curb the abuse of narcotic painkillers, the U.S. Food and Drug Administration is requiring drug makers to educate doctors about the risks of long-acting and extended-release forms of the drugs.

"Prescription- abuse is our nation's fastest-growing drug problem," FDA commissioner Dr. Margaret Hamburg said during a Monday afternoon press conference.

Commonly prescribed drugs that come in longer-acting forms include , and fentanyl.

The continuing-education programs will be based on FDA-created blueprints. The agency expects the more than 20 companies that make these drugs to provide grants to firms that specialize in medical continuing education. These firms will, in turn, develop and administer the programs under FDA supervision and provide them to doctors for free.

Although all painkillers carry risk of abuse, overdose and death, the extended-release and time-release forms of the drugs are particularly risky. Because they act in the body over longer periods, they are more likely to cause problems, Hamburg said.

"The number of people harmed by these long-acting or extended-release opioids due to misprescribing, misuse and abuse ... continues to increase dramatically," Hamburg said.

In 2008, nearly 15,000 Americans died from of these drugs. In 2009, there were more than 15,500 deaths from opioid painkillers -- almost four times as many as in 1999, according to the U.S. .

In addition, more than 2 million emergency-room visits in 2010 involved abuse or misuse of prescription drugs -- almost half of all drug-related visits. Of these visits, more than 15 percent involved opioid medications, Hamburg said.

The drugs are widely prescribed. It is estimated that nearly 23 million for extended-release and long-acting opioids were issued in 2011, Hamburg said. It is estimated that more than 320,000 prescribers listed with the U.S. Drug Enforcement Administration wrote at least one prescription for opioid painkillers in 2011, according to the FDA.

Despite these problems, Hamburg said, patients who need these drugs must have access to them.

"Educating health care professionals on how to safely prescribe extended-release and long-acting opioids is essential to address this critical public health issue," she said.

The FDA hopes that over the next three years, 60 percent of the 320,000 prescribing doctors will have been trained, Hamburg said.

Along with the programs for doctors, the FDA also is mandating that manufacturers provide FDA-approved patient-education materials on the safe use of these drugs. The material appears on a single page in consumer-friendly language, and will be given to patients every time they fill a prescription.

Both the drug companies and the FDA will review the progress and success of these programs. Based on the reviews, the agency may require the companies to provide additional elements to ensure success.

The first programs under the FDA's new requirement are expected to be launched by March 1. Although no doctor currently is required to take the two- to three-hour continuing-education program, the Obama administration is urging Congress to make such programs mandatory.

Explore further: Many who first misuse prescription pills get them from friends, family: report

More information: For more about narcotic painkillers, visit the U.S. National Library of Medicine.

Related Stories

Many who first misuse prescription pills get them from friends, family: report

April 25, 2012
(HealthDay) -- A new U.S. government analysis shows that more than 70 percent of people who first misuse prescription medications get those pills from their friends or relatives.

FDA weighs over-the-counter switch for key drugs

March 8, 2012
Some of the most widely used prescription drugs, including those to treat cholesterol and high blood pressure, could be available over the counter under a new proposal being weighed by government regulators.

Harmful patterns of painkiller prescriptions seen among methadone patients

November 28, 2011
A new study has shown harmful prescription patterns of powerful painkillers among a substantial number of Ontario patients who received methadone therapy to treat their opioid addiction.

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.